NEURON23

Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease. The company was founded in 2018 and is based in San Francisco, California, United States.

#People #Financial #Event #Website #More

NEURON23

Industry:

Health Care Medical Pharmaceutical

Founded:

2018-01-01

Address:

San Francisco, California, United States

Country:

United States

Website Url:

http://www.neuron23.com

Total Employee:

11+

Status:

Active

Total Funding:

213.5 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress

Current Advisors List

beth-seidenberg_image

Beth Seidenberg Board Member @ Neuron23
Board_member
2020-12-01

not_available_image

Amrit Nagpal Board Member @ Neuron23
Board_member
2020-12-01

not_available_image

Michael Almstetter Board Member @ Neuron23
Board_member
2020-12-01

jim-scopa_image

Jim Scopa Board Of Director, Chair of Audit Committee @ Neuron23
Board_member
2022-03-30

valentin-barsan_image

Valentin Barsan Board of Director @ Neuron23
Board_member
2022-03-30

kevin-raidy_image

Kevin Raidy Board Member @ Neuron23
Board_member
2020-12-01

Current Employees Featured

sam-jackson_image

Sam Jackson
Sam Jackson Chief Medical Officer @ Neuron23
Chief Medical Officer
2022-04-01

nancy-stagliano_image

Nancy Stagliano
Nancy Stagliano Chief Executive Office @ Neuron23
Chief Executive Office
2020-10-01

adam-knight_image

Adam Knight
Adam Knight Founder & Chief Business Officer @ Neuron23
Founder & Chief Business Officer

Founder

adam-knight_image

Adam Knight

Investors List

surveyor-capital_image

Surveyor Capital

Surveyor Capital investment in Series C - Neuron23

cowen-healthcare-investments_image

Cowen Healthcare Investments

Cowen Healthcare Investments investment in Series C - Neuron23

acorn-bioventures_image

Acorn Bioventures

Acorn Bioventures investment in Series C - Neuron23

westlake-village-biopartners_image

Westlake Village BioPartners

Westlake Village BioPartners investment in Series C - Neuron23

softbank-vision-fund_image

SoftBank Vision Fund

SoftBank Vision Fund investment in Series C - Neuron23

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Series C - Neuron23

redmile-group_image

Redmile Group

Redmile Group investment in Series C - Neuron23

hbm-partners_image

HBM Partners

HBM Partners investment in Series C - Neuron23

kleiner-perkins-caufield-byers_image

Kleiner Perkins

Kleiner Perkins investment in Series C - Neuron23

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Series C - Neuron23

Key Employee Changes

Date	New article
2022-04-12	Neuron23 Appoints Sam Jackson, M.D., MBA, as Chief Medical Officer

Official Site Inspections

http://www.neuron23.com Semrush global rank: 5.5 M Semrush visits lastest month: 1.55 K

Host Informations
Whois Informations

Loading ...

More informations about "Neuron23" on Search Engine